Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.

Bibliographic Details
Corporate Authors:	United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1992.
Series:	U.S. Congressional Hearings.
Subjects:	Orphan drugs > Law and legislation > United States. Drugs > Law and legislation > United States. Antitrust law > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Available Online